## Core Concept
The question pertains to the long-term complications and mortality causes in patients post-kidney transplant. Patients who have undergone kidney transplantation are at risk for various complications, both related to the surgery and the immunosuppressive therapy required to prevent graft rejection. The leading causes of death in these patients often relate to cardiovascular diseases, infections, and malignancies, which are exacerbated or directly caused by immunosuppression.

## Why the Correct Answer is Right
Cardiovascular disease (**CVD**) is a major cause of morbidity and mortality in kidney transplant recipients. The risk factors for CVD in these patients include pre-existing conditions such as hypertension, diabetes mellitus, dyslipidemia, and the use of certain immunosuppressive drugs that can contribute to these conditions. Long-term immunosuppression can lead to accelerated atherosclerosis and an increased risk of cardiovascular events. Given that the patient is 1 year post-transplant and considered stable, the risk of acute rejection or immediate post-surgical complications is lower, making chronic complications like CVD more relevant.

## Why Each Wrong Option is Incorrect
- **Option A:** While infections are a significant risk, especially in the early post-transplant period or in patients with higher levels of immunosuppression, they are not the most common cause of death in stable, long-term survivors.
- **Option B:** Malignancy is a risk due to immunosuppression, but it tends to manifest over a longer period and is not the leading cause of death in the first few years post-transplant.
- **Option C:** This option is not provided, but based on the correct answer being , we can infer that option is likely related to cardiovascular causes.

## Clinical Pearl / High-Yield Fact
A key point to remember is that cardiovascular disease is a leading cause of death in kidney transplant recipients, even in those who are considered stable and long-term survivors. This highlights the importance of managing cardiovascular risk factors aggressively in the post-transplant period.

## Correct Answer: . Cardiovascular disease.